## Note
nid: 1496971493857
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Zanki_Step_2, #AK_Step1_v11::#Pixorize::03_Pharm::06_Cardio::Hydralazine, #AK_Step2_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step2_v11::!Shelf::IM, #AK_Step2_v11::#OME_banner, #AK_Step2_v11::#Resources_by_rotation::IM::uw::cardio::cardio_zanki, #AK_Step2_v11::#Subjects::Cardiology::03_Heart_Failure::Treatment, #AK_Step2_v11::Original_decks::Zanki_Step_2::IM::Cardio
markdown: false

### Text
Medications that have been shown to <u>improve long-term
survival</u> in patients with <b>LV systolic dysfunction</b>
include:
<div>
  1. <b>{{c1::</b><b>β</b><b>-blockers}}</b>
</div>
<div>
  2. <b>{{c2::ACE inhibitors}}</b>
</div>
<div>
  3. <b>{{c2::ARBs}}</b>
</div>
<div>
  4. <b>{{c3::Mineralocorticoid receptor antagonists}}</b>
</div>
<div>
  5. Hydralazine and nitrates in African American patients
</div>

### Extra
<i><u>helpful trick</u>: drugs that improve survival usually will
have <b>some effect on the renin-angiotensin-aldosterone
system</b>!</i>
<div>
  <i>1. Renin - β-blockers</i>
</div>
<div>
  <i>2. Angiotensin - ACE inhibitors/ARBs</i>
</div>
<div>
  <i>3. Aldosterone - mineralocorticoid receptor antagonists (e.g.
  spironolactone, eplrenon)</i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_7.png"></a>
</div>

### Additional Resources


### One by one

